Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2025-04-02 00:00:00 ET · period of report 2025-04-01 · accession 0000950170-25-049800 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-04-02 | 2025-04-01 | CORT | Guyer William | Chief Development Off | S - Sale+OE | $114.51 | -678 | 5,487 | -11% | -$77.6K |
| DT | 2025-04-02 | 2025-04-01 | CORT | Guyer William | Chief Development Off | M - OptEx | $21.65 | +678 | 6,165 | +12% | +$14.7K |
| DT | 2025-04-02 | 2025-04-01 | CORT | Guyer William | Chief Development Off | M - OptEx | $0.00 | -678 | 449.3K | -0.2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-01 | S | D | 678 | $114.51 | 5,487 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.29 to $114.71 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 2 | Common | Common Stock | 2025-04-01 | M | A | 678 | $21.65 | 6,165 | D | — | — | |
| 3 | Derivative | Stock option (right to buy) | 2025-04-01 | M | D | 678 | $0.00 | 449,322 | D | $21.65 · — to 2031-09-01 | 678 Common Stock | (F3) Fully exercisable. |